Biosciences Inc Neurocrine serves as Executive at Voyager Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Biosciences Inc Neurocrine has executed 2 insider transactions totaling $89.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 23, 2023 involved purchasing 4,395,588 shares valued at $39.0M.
Biosciences Inc Neurocrine currently holds 8,575,316 shares of Voyager Therapeutics, Inc. (VYGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biosciences Inc Neurocrine has been a net buyer of VYGR stock. They have purchased $89.0M and sold $0 worth of shares.
Biosciences Inc Neurocrine's most recent insider trade was on Feb 23, 2023, when they purchased 4,395,588 shares at $8.88 per share.
Get notified when new Form 4 filings are submitted
| $11.96 |
| Discretionary |